Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Appointed director
Quarterly results

Axogen, Inc. (AXGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/04/2021 GN Axogen, Inc. to Participate at Upcoming February Investor Conferences
02/01/2021 GN Axogen, Inc. to Report Fourth Quarter and Full-Year 2020 Financial Results and Host Conference Call on February 22, 2021
01/11/2021 GN Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2020
01/05/2021 GN Axogen to Participate at AAHS ASPN ASRM 2021 Virtual Annual Meetings
12/23/2020 GN Axogen Sponsors Donate Life at 2021 Virtual Rose Parade Celebration
10/08/2020 GN Axogen, Inc. to Report Third Quarter 2020 Financial Results and Host Conference Call on October 29, 2020
09/30/2020 GN Axogen, Inc. Appoints Paul G. Thomas to Board of Directors
09/25/2020 GN Axogen, Inc. to Present at the JMP Securities MedTech Bio Summit
08/31/2020 GN Axogen, Inc. to Present at the Cantor Virtual Global Healthcare Conference
07/15/2020 GN Axogen, Inc. to Report Second Quarter 2020 Financial Results and Host Conference Call on August 5, 2020
07/01/2020 GN Axogen Announces New Seven-Year Financing Agreement with Oberland Capital and Provides Preliminary Second Quarter Revenue Estimate
06/01/2020 GN Axogen, Inc. Announces Planned Retirement of Greg Freitag and Appoints Brad Ottinger as General Counsel and Chief Compliance Officer
05/20/2020 GN Axogen, Inc. to Present at the Jefferies Virtual Healthcare Conference
04/15/2020 GN Axogen, Inc. to Report First Quarter 2020 Financial Results and Host Conference Call on May 6, 2020
01/13/2020 GN Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2019 and Provides 2020 Annual Guidance
01/08/2020 GN Axogen Sponsored RANGER® Registry Reaches 2,000 Nerve Repair Enrollment Milestone
01/02/2020 GN Axogen to Participate at AAHS ASPN ASRM 2020 Annual Meetings
01/02/2020 GN Axogen, Inc. to Participate at JP Morgan 38th Annual Healthcare Conference
12/18/2019 GN Axogen awarded research grant from the Advanced Regenerative Manufacturing Institute
12/04/2019 GN Avance® Nerve Graft Recipient Selected to Ride on Donate Life Rose Parade® Float
11/21/2019 GN Axogen, Inc. to Participate at Piper Jaffray 31st Annual Healthcare Conference
11/11/2019 GN Axogen, Inc. to Participate at Jefferies London Healthcare Conference
10/23/2019 GN Axogen, Inc. to Report Third Quarter 2019 Financial Results and Host Conference Call on November 6, 2019
09/19/2019 GN Axogen, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
09/11/2019 GN Bragar Eagel & Squire is Investigating Certain Officers and Directors of Mammoth Energy, Acer Therapeutics, Realogy Holdings, and AxoGen and Encourages Investors to Contact the Firm
08/27/2019 GN Axogen to Participate in the 74th Annual American Society for Surgery of the Hand Meeting
08/14/2019 GN Bragar Eagel & Squire is Investigating Certain Officers and Directors of Lannett, Molson Coors, AxoGen, and American Renal Associates and Encourages Investors to Contact the Firm
07/29/2019 GN Axogen, Inc. to Participate at Canaccord Genuity 39th Annual Growth Conference
07/26/2019 GN Axogen Announces Publication of the 100th Peer-Reviewed Clinical Paper Featuring its Product Portfolio for Peripheral Nerve Repair
07/22/2019 GN Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of AxoGen (NASDAQ: AXGN) and Encourages AxoGen Investors to Contact the Firm
07/19/2019 GN SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of AxoGen, Inc. - AXGN
05/23/2019 GN Axogen, Inc. to Participate at Upcoming Investor Conferences
05/02/2019 GN Axogen, Inc. Appoints New Members to Board of Directors
04/22/2019 GN Axogen, Inc. Announces Completion of Planned Interim Analysis and One-Time Enrollment Expansion for RECON® Study
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy